Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07220096
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Survey — OTHERParticipants will complete an intake survey and repeat surveys at the following time points: * Baseline * 3 months * 6 months * 9 months * 12 months * 18 months * 24 months * 36 months * 48 months * 60 months
Study Details
The goal of this research study is to learn about: The effect of enrolling in the YOLC program on patient satisfaction with care provided, The needs of patients younger than 50 with lung cancer and their family, and The impact of participating in peer support networks on these patients.
Key Dates
- Start date
- Sep 25, 2025
- Status verified
- Apr 2026
- Primary completion
- May 31, 2029
- Completion
- May 31, 2031
Study Design
- Enrollment
- 75 participants (estimated)
Arms
- Arm: Assessment of Patients with Young-Onset Lung CancerThis is a registry trial enrolling participants with NSCLC diagnosed and histologically confirmed prior to the age of 50 years identified. Each participant will participate in an intake survey as well as periodic recurring surveys to provide feedback to the YOLC Program, to elucidate the individual participant's care needs, and to assess changes in personal goals, wellness, financial impact, and family support over time
Primary Outcome Measure
Participant satisfaction with care [ Time Frame: Through study completion; an average of 5 year ]
Central Contacts
- Eric Singhi, MD713-745-2263
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | Eric Singhi, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
Related Studies
- Metabolic Biomarkers in Thoracic CancersRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Couple-Based Meditation for Metastatic Lung Cancer Patients and Their PartnersRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Collection of Sputum and Labeling for Lung CancerRecruiting · bioAffinity Technologies Inc. · Summit, New Jersey
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California